Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.
about
Natural products: a continuing source of novel drug leadsEpothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: a phase II study of the Department of Defense Prostate Cancer Clinical Trials ConsortiumWeekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial.Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelTubulin inhibitors: a patent review.
P2860
Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@ast
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@en
type
label
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@ast
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@en
prefLabel
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@ast
Phase I/II study of sagopilone ...... inum-sensitive ovarian cancer.
@en
P2093
P2860
P356
P1476
Phase I/II study of sagopilone ...... tinum-sensitive ovarian cancer
@en
P2093
C Stredder
M Giurescu
S McMeekin
T Schmelter
P2860
P2888
P356
10.1038/BJC.2011.499
P407
P577
2011-11-22T00:00:00Z